- Home
- GLAD vs MNMD Comparison
GLAD vs MNMD Comparison
Compare GLAD & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLAD
- MNMD
- Stock Information
- Founded
- GLAD 2001
- MNMD 2019
- Country
- GLAD United States
- MNMD United States
- Employees
- GLAD N/A
- MNMD N/A
- Industry
- GLAD Finance/Investors Services
- MNMD Pharmaceuticals and Biotechnology
- Sector
- GLAD Finance
- MNMD Health Care
- Exchange
- GLAD Nasdaq
- MNMD Nasdaq
- Market Cap
- GLAD 644.5M
- MNMD 559.5M
- IPO Year
- GLAD N/A
- MNMD N/A
- Fundamental
- Price
- GLAD $27.60
- MNMD $6.19
- Analyst Decision
- GLAD Hold
- MNMD Strong Buy
- Analyst Count
- GLAD 1
- MNMD 9
- Target Price
- GLAD $23.00
- MNMD $25.75
- AVG Volume (30 Days)
- GLAD 92.7K
- MNMD 1.3M
- Earning Date
- GLAD 04-30-2025
- MNMD 03-06-2025
- Dividend Yield
- GLAD 8.62%
- MNMD N/A
- EPS Growth
- GLAD 60.05
- MNMD N/A
- EPS
- GLAD 4.63
- MNMD N/A
- Revenue
- GLAD $95,360,000.00
- MNMD N/A
- Revenue This Year
- GLAD N/A
- MNMD N/A
- Revenue Next Year
- GLAD $10.81
- MNMD N/A
- P/E Ratio
- GLAD $5.96
- MNMD N/A
- Revenue Growth
- GLAD 5.53
- MNMD N/A
- 52 Week Low
- GLAD $19.20
- MNMD $5.03
- 52 Week High
- GLAD $30.43
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- GLAD 47.63
- MNMD 39.74
- Support Level
- GLAD $27.45
- MNMD $6.51
- Resistance Level
- GLAD $27.83
- MNMD $7.05
- Average True Range (ATR)
- GLAD 0.51
- MNMD 0.36
- MACD
- GLAD 0.11
- MNMD 0.02
- Stochastic Oscillator
- GLAD 76.80
- MNMD 21.10
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.